TARS – Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals, Inc.

TARS

$61.55

Name : Tarsus Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $2,648,124,672.00

EPSttm : -1.11

Tarsus Pharmaceuticals, Inc.

$61.55

3.20%

$1.91

TARS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

12.15

Margin Of Safety %

Put/Call OI Ratio

1.89

EPS Next Q Diff

-0.04

EPS Last/This Y

EPS This/Next Y

3.46

Price

61.63

Target Price

Analyst Recom

1.11

Performance Q

-15.71

Upside

-164.3%

Beta

0.51

Ticker: TARS

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	TARS	59.61	2.32	0.67	15804
2026-05-12	TARS	59.82	2.31	0.43	15808
2026-05-13	TARS	64.6	2.29	0.20	15816
2026-05-14	TARS	65.21	2.29	367.33	15825
2026-05-15	TARS	62.47	2.06	0.39	14735
2026-05-18	TARS	62.77	1.79	0.17	8303
2026-05-19	TARS	61.28	1.97	1.16	8971
2026-05-20	TARS	64.7	1.97	1.00	9023
2026-05-21	TARS	63.44	1.97	0.08	9031
2026-05-22	TARS	62.17	1.94	1.56	9087
2026-05-26	TARS	61.22	1.94	5.00	9113
2026-05-27	TARS	60.05	1.94	0.12	9137
2026-05-28	TARS	59.5	1.94	0.00	9140
2026-05-29	TARS	59.32	1.94	0.19	9148
2026-06-02	TARS	57.43	1.92	0.27	9188
2026-06-03	TARS	58.75	1.92	0.23	9201
2026-06-04	TARS	60.36	1.92	0.08	9203
2026-06-05	TARS	59.2	1.91	1.00	9216
2026-06-08	TARS	59.57	1.89	0.29	9251
2026-06-09	TARS	61.59	1.89	110.10	9268
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	TARS	59.61	58.3	-	-0.53
2026-05-12	TARS	59.77	48.8	-	-0.55
2026-05-13	TARS	64.62	48.8	-	-0.55
2026-05-14	TARS	65.14	43.4	-	-0.71
2026-05-15	TARS	62.42	43.4	-	-0.71
2026-05-18	TARS	62.82	43.4	-	-0.71
2026-05-19	TARS	61.23	43.4	-	-0.71
2026-05-20	TARS	64.84	43.4	-	-0.71
2026-05-21	TARS	63.46	43.4	-	-0.71
2026-05-22	TARS	62.24	43.4	-	-0.71
2026-05-26	TARS	61.22	47.6	-	-0.59
2026-05-27	TARS	60.03	47.6	-	-0.59
2026-05-28	TARS	59.54	47.6	-	-0.59
2026-05-29	TARS	59.34	47.6	-	-0.59
2026-06-01	TARS	59.00	47.6	-	-0.59
2026-06-02	TARS	57.34	47.6	-	-0.59
2026-06-03	TARS	58.72	47.6	-	-0.59
2026-06-04	TARS	60.38	47.6	-	-0.59
2026-06-05	TARS	59.20	47.6	-	-0.59
2026-06-08	TARS	59.57	47.6	-	-0.59
2026-06-09	TARS	61.63	47.6	-	-0.59
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	TARS	-5.84	-1.41	11.31
2026-05-12	TARS	-5.84	-1.41	11.95
2026-05-13	TARS	-5.84	-1.41	11.95
2026-05-14	TARS	-5.84	-1.41	11.95
2026-05-15	TARS	-5.84	-1.41	11.95
2026-05-18	TARS	-5.84	-3.55	11.96
2026-05-19	TARS	-5.83	-3.55	11.96
2026-05-20	TARS	-5.83	-3.55	11.96
2026-05-21	TARS	-5.83	-3.55	11.96
2026-05-22	TARS	-5.83	-3.55	11.93
2026-05-26	TARS	-5.98	1.08	11.93
2026-05-27	TARS	-5.98	1.08	11.93
2026-05-28	TARS	-5.98	1.08	12.15
2026-05-29	TARS	-5.98	1.08	12.15
2026-06-02	TARS	-5.98	0.29	12.15
2026-06-03	TARS	-5.98	0.29	12.15
2026-06-04	TARS	-5.98	0.29	12.15
2026-06-05	TARS	-5.98	0.29	12.15
2026-06-08	TARS	-5.98	0.92	12.15
2026-06-09	TARS	-5.98	0.92	12.15
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.16

Avg. EPS Est. Current Quarter

-0.25

Avg. EPS Est. Next Quarter

-0.2

Insider Transactions

-5.98

Institutional Transactions

0.92

Beta

0.51

Average Sales Estimate Current Quarter

167

Average Sales Estimate Next Quarter

175

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

27.7

Max Drawdown 5-Year %

-71.3

Target Price

P/E

Forward P/E

20.29

PEG

P/S

4.95

P/B

7.59

P/Free Cash Flow

EPS

-1.13

Average EPS Est. Cur. Y

-0.59

EPS Next Y. (Est.)

2.87

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-9.02

Relative Volume

Return on Equity vs Sector %

-41.3

Return on Equity vs Industry %

-25.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.1

EBIT Estimation

◆ TARS Healthcare

$61.55

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

13/25

Volume

4/15

Valuation

15/20

TP/AR

2/10

Options

1/10

RSI

49.9

Range 1M

55.6%

Sup Dist

5.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

28/30

Estimates

3/20

Inst/Vol

5/15

Options

2/10

EPS Yr

61.1%

EPS NY

590.1%

52W%

49.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +60.2% upside

Quality

6/30

Valuation

14/30

Growth

20/25

Stability

8/10

LT Trend

0/5

Upside

+60.2%

Quality

Tarsus Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 370

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotilaner ophthalmic solution for the treatment of demodex blepharitis caused by the infestation of Demodex mites. It sells its products to specialty pharmacies and distributors, as well as clinics, hospitals, pharmacies, and federal healthcare programs. The company also develops TP-04, a sterile aqueous gel formulation of lotilaner in Phase 2 trial for the treatment of ocular rosacea; and TP-05, an oral tablet formulation of lotilaner in Phase 2 trial for the prevention of Lyme disease, as well as in pre-clinical studies for community malaria reduction. In addition, it is developing the lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. The company has a development and license agreement with Xi An Grand Chang An Pharmaceutical Co., Ltd. for the development and commercialization of TP-03 in China for the treatment of Demodex blepharitis and meibomian gland disease. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

TARS

Latest News

—

Caricamento notizie per TARS…

stock quote shares TARS – Tarsus Pharmaceuticals Inc Stock Price stock today

news today TARS – Tarsus Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch TARS – Tarsus Pharmaceuticals Inc yahoo finance google finance

stock history TARS – Tarsus Pharmaceuticals Inc invest stock market

stock prices TARS premarket after hours

ticker TARS fair value insiders trading

TARS – Tarsus Pharmaceuticals Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: TARS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y